Teva Prices Offering of $2B in Senior Notes
Posted on December 13, 2012 at 17:45 PM EST
Teva Pharmaceutical Industries Limited (NYSE: TEVA ) announced today that it successfully priced a debt offering by its special purpose finance subsidiaries, consisting of two tranches: * $700,000,000 of 2.250% fixed rate senior notes maturing in March 2020 issued by Teva Pharmaceutical Finance IV, LLC; and * $1,300,000,000